Journal article · 2026 · Open access

GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps

Nils Werner, Vinay Pitchika, C.V. Bumm, Katrin Heck, Mathias Folwaczny, Falk Schwendicke

Journal of Dental Research, 220345261488338 · Published 14 October 2026 · DOI 10.1177/00220345261488338

Open full textCite this paper

In brief

“GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps” is a 2026 journal article by Nils Werner and 5 co-authors, published in Journal of Dental Research. OpenAlex counts 1 citations as of 17 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Dental Research.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
3.48
References
38
Authors
6

Abstract

GLP-1RAs (glucagon-like peptide-1 receptor agonists) have become one of the fastest-growing drug classes worldwide, with prescriptions for obesity treatment increasing by 587% from 2019 to 2024. While their metabolic and cardiovascular benefits are well established, the implications for oral health remain largely unexamined. Preclinical evidence consistently demonstrates anti-inflammatory and osteoprotective effects on periodontal and peri-implant tissues: GLP-1RAs promote osteogenic differentiation of periodontal ligament stem cells, reduce alveolar bone resorption in animal models of periodontitis, and enhance implant osseointegration in diabetic rats. However, these findings are based exclusively on in vitro and animal studies, with only a single retrospective cohort study providing limited clinical data. Conversely, several oral adverse effects have been reported based on pharmacovigilance analyses, including xerostomia, dysgeusia, and anosmia, particularly for semaglutide. Gastrointestinal side effects, particularly nausea (15% to 50%), vomiting (5% to 24%), and gastroesophageal reflux, pose a plausible but unquantified risk for tooth erosion and secondary caries. A bidirectional link between GLP-1 signaling and the oral microbiota, mediated by bacterial dipeptidyl peptidase (DPP)-4-like enzymes that degrade endogenous GLP-1, adds further complexity. Despite this breadth of potential interactions, no prospective study has used any dental outcome as an endpoint in patients receiving GLP-1RAs. This critical appraisal synthesizes the evidence across multiple dental disciplines, grades it in each domain, and identifies the gaps that demand urgent investigation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Werner, N., Pitchika, V., Bumm, C., Heck, K., Folwaczny, M., & Schwendicke, F. (2026). GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps. Journal of Dental Research, 220345261488338. https://doi.org/10.1177/00220345261488338

MLA 9

Werner, Nils, et al. “GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps.” Journal of Dental Research, 2026, p. 220345261488338. https://doi.org/10.1177/00220345261488338.

Chicago

Werner, Nils, Vinay Pitchika, C.V. Bumm, Katrin Heck, Mathias Folwaczny, and Falk Schwendicke. 2026. “GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps.” Journal of Dental Research: 220345261488338. https://doi.org/10.1177/00220345261488338.

Harvard

Werner, N. et al. (2026) ‘GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps’, Journal of Dental Research, p. 220345261488338. doi:10.1177/00220345261488338.

IEEE

N. Werner, V. Pitchika, C. Bumm, K. Heck, M. Folwaczny, and F. Schwendicke, “GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps,” Journal of Dental Research, p. 220345261488338, 2026, doi: 10.1177/00220345261488338.

BibTeX

@article{werner2026receptor,
  title     = {{GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps}},
  author    = {Werner, Nils and Pitchika, Vinay and Bumm, C.V. and Heck, Katrin and Folwaczny, Mathias and Schwendicke, Falk},
  journal   = {Journal of Dental Research},
  year      = {2026},
  pages     = {220345261488338},
  doi       = {10.1177/00220345261488338},
  url       = {https://doi.org/10.1177/00220345261488338}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research

  • GLP-1 receptor agonists
  • oral health
  • periodontitis
  • peri-implant disease
  • periodontal ligament stem cells
  • osteogenic differentiation
  • alveolar bone loss
  • osseointegration

Work with this paper

Most-cited papers in Dentistry

All highly cited Dentistry papers

Questions about this paper

How do I cite this paper in APA style?

Werner, N., Pitchika, V., Bumm, C., Heck, K., Folwaczny, M., & Schwendicke, F. (2026). GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps. Journal of Dental Research, 220345261488338. https://doi.org/10.1177/00220345261488338

How many times has this paper been cited?

1 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Dental Research: sign in and open the full text from this page.

Who wrote this paper?

Nils Werner, Vinay Pitchika, C.V. Bumm, Katrin Heck, Mathias Folwaczny, Falk Schwendicke.

What is the DOI of this paper?

10.1177/00220345261488338, permanently at https://doi.org/10.1177/00220345261488338. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.